12th ESO-ESMO Masterclass in Clinical Oncology
30 ESCO credits
16.03.2013 - 21.03.2013
Ermatingen, Switzerland
MASTERCLASS
Description
Chairs: N. Pavlidis, GR - R.A. Stahel, CH
Scientific Co-ordinators: W. Gatzemeier, IT - R. Popescu, CH
AIMS AND OBJECTIVES
This clinically oriented educational programme has been designed for medical or clinical oncologists who wish to improve their skills or those who are preparing for the national board exam. The programme will expose participants to a full spectrum of issues in clinical oncology and to practice-oriented training. The programme focuses on breast, gastro-intestinal, genitourinary, gynaecological, head and neck and lung cancers.
Spotlight sessions will facilitate compact update on haematological diseases, supportive care, treatment of melanoma, radiology for oncology, bone health and cancer, cancer of unknown primary, biology of cancer, oral therapy, pain control, survivorship and side effects and rare cancers.
TEACHING FORMAT
The Masterclass offers plenary lectures regarding state-of-the-art clinical evaluation and treatments with reference to clinical guidelines which will conclude in take-home messages. The Clinical Sessions will be complemented by Tumour Board discussions. Furthermore, participants will deliver case presentations within small groups and discuss these with the chairmen and the faculty.
All participants will reside at the course venue and participation is compulsory throughout the course. The Masterclass will be entirely in English and fluency in English is necessary for admission. Participants of the concomitant Masterclass in Nursing Oncology will attend selected medical sessions whilst the oral cancer therapy, pain control, Survivorship and “new” oncological emergencies sessions will be attended jointly.
THE MASTERCLASS IS:
• A 5-day residential educational event
• Full immersion
• Clinically-oriented
• Multidisciplinary
• An international faculty of top experts delivering lectures focusing on genito-urinary, breast, gynaecological, head and neck, gastro-intestinal and lung cancers.
General information
ORGANISING SECRETARIAT
Francesca Marangoni
European School of Oncology
Via del Bollo, 4
20123 Milan, Italy
Ph: +39 02 85464525
Fax: +39 02 85464545
Email: fmarangoni@eso.net
ACCREDITATION
The Accreditation Council for Oncology in Europe (ACOE) has recommended that the event be granted 27 European Continuing Medical Education Credits (ECMEC). The ECMEC will be recognised within the different European States which have agreed to participate in this European system, and by the American Medical Association (AMA) as AMA Pra Category 1 Credits.
The event has also been accredited with 25 ESMO-MORA cat. 1 points.
ACKNOWLEDGEMENTS
ESO wishes to express its appreciation to Wolfsberg Centre for its consideration and support to the 2013 Masterclass.
The Masterclass is part of the Sharing Progress in Cancer Care programme whose sustaining members are:
- Platinum members: Amgen and Eisai
- Gold members: Eli Lilly, GlaxoSmithKline Oncology, Helsinn, Merck Serono, Novartis Oncology and Roche
- Silver members: Boehringer Ingelheim, Celgene Corporation, Genomic Health and Sanofi Oncology
Faculty list
FACULTY (as of January 2013)
M. Aapro, IMO - Clinique de Genolier, Department of Oncology, Genolier, CH
N. Aaronson, Antoni van Leeuwenhoek Hospital, Department of Psychosocial Research and Epidemiology, Amsterdam, NL
J. Bernier, Genolier Swiss Medical Network, Department of Radiotherapy, Genolier, CH
P. Casali, National Cancer Institute, Department of Medical Oncology, Milan, IT
A. Cervantes, Hospital Clinico Universitario, Hematology And Medical Oncology Department, Valencia, ES
A. Dietz, University of Leipzig, Department of Otolaryngology, Leipzig, DE
T. Eisen, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK
C. Faivre-Finn, Christie Hospital NHS Foundation Trust, Department of Clinical Oncology, Manchester, UK
K. Fizazi, Institut Gustave Roussy, Department of Medicine, Villejuif, FR
S.D. Fosså, Univesirsity of Oslo - Institute of Clinical Medicine, Oslo, NO
M. Garassino, National Cancer Institute, Department of Medical Oncology, Milan, IT
W. Gatzemeier, Humanitas Clinical Institute, Breast Unit, Rozzano, IT
M. Ghielmini, Oncology Institute of Southern Switzerland, Division of Medical Oncology, Bellinzona, CH
N. Harbeck, Klinikum Grosshadern, Breast Centre of Munich University, Munich, DE
A. Horwich, The Royal Marsden Hospital, Department of Radiotherapy, Sutton, UK
R. Huddart, The Institute of Cancer Research (ICR) – Royal Marsden Hospital, Sutton Surrey, UK
C.H. Köhne, Klinikum Oldenburg, Klinik für Onkologie / Hämatologie, Oldenburg, DE
P. Lorigan, University of Manchester, Institute of Cancer Sciences, Manchester, UK
D. Lüftner, Charité Hospital, Dept. of Oncology Haematology, Berlin, DE
O. Pagani, Oncology Institute of Southern Switzerland (IOSI), Department
N. Pavlidis, University of Ioannina, Division of Medical Oncology, Ioannina, GR
S. Peters, Centre Hospitalier Universitaire Vaudois, Lausanne Cancer Center, Lausanne, CH
R. Popescu, Hirslanden Clinic, Tumor Center, Department of Medical Oncology, Aarau, CH
K. Redmond, Cancer World Magazine, Lugano, CH
D. Schrijvers, Ziekenhuisnetwerk Antwerpen-Middelheim, Department of Haemato-Oncology, Antwerp, BE
D. Sebag-Montefiore, University of Leeds, Leeds Cancer Centre, Department of Clinical Oncology, Leeds, UK
C. Sessa, Oncology Institute of Southern Switzerland, Division of Medical Oncology, Bellinzona, CH
R.A. Stahel, University Hospital Zurich, Clinic and Policlinic for Oncology, Zurich, CH
F. Strasser, Cantonal Hospital, Department Internal Medicine & Palliative Care Centre, St. Gallen, CH
N. Tunariu, Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, London, UK
J.B. Vermorken, University Hospital Antwerp, Department of Oncology, Edegem, BE
G. Viale, European Institute of Oncology, Department of Pathology, and Milan University, Milan, IT
W. Weder, University Hospital Zurich, Division of Thoracic Surgery, Zurich, CH
Programme
16 March
Participants' arrival, airport transfers, registration | |
14:30 | Clinical session Genito-urinary cancers I Chair: K. Fizazi, FR |
Prostate cancer:
| |
16:10 | Clinical session Genito-urinary cancers II |
| Bladder cancer:
Renal cancer:
|
17:50 | Coffee break |
18:20 | Tumour board Genito-urinary cancers |
20:30 | Dinner |
17 March
8:30 | Clinical session Gastro-intestinal tumours I Chair: D. Sebag-Montefiore, UK |
Colon cancer:
| |
10:00 | Coffee break |
10:30 | Clinical session Gastro-intestinal tumours II |
|
|
12:00 | Tumour board Gastro-intestinal tumours A. Cervantes, ES - D. Sebag-Montefiore, UK - C.H. Köhne, DE |
13:00 | Sponsored lecture Management of senior adults with prostate cancer (SPCC lecture by Sanofi) M. Aapro, CH |
13:30 | Lunch |
14:30 | Spotlight session 1 Haematological diseases - focus on lymphomas |
15:15 | Spotlight session 2 Supportive care |
|
|
16:00 | Coffee break |
16:30 | Case presentations by participants |
18:00 | Sponsored lecture Cancer Cachexia Syndrome: Mechanism based clinical approach to achieve reasonable outcomes (SPCC lecture by Helsinn) F. Strasser, CH |
19:30 | Dinner |
18 March
8:30 | Clinical session Breast cancer I Chair: G. Viale, IT |
|
|
10:15 | Coffee break |
10:45 | Clinical session Breast cancer II |
|
|
12:15 | Tumour board Breast cancer |
13:15 | Lunch |
14:30 | Spotlight session 3 Advances in systemic treatment of melanoma P. Lorigan, UK |
15:15 | Case presetation by participants |
16:45 | Coffee break |
15:00 | Tumour board Head and neck cancer |
17:15 | Spotlight session 4 Essentials in imaging radiology for oncologists Tunariu, UK |
17:45 | Spotlight session 5 Bone health and cancer S. Peters, CH |
18:15 | Spotlight session 6 Cancer of unknown primary |
19:30 | Dinner |
19 March
8:30 | Clinical session Gynaecological cancers |
| |
10:30 | Coffee break |
11:00 | Clinical session Head and neck cancer |
|
|
13:00 | Lunch |
14:30 | Tumour board Gynaecological cancers |
15:00 | Tumour board Head and neck cancer J. Bernier, CH - A. Dietz, DE - J.B. Vermorken, BE |
15:30 | Spotlight session 6 Biology of cancer |
16:00 | Free time |
19:00 | Special evening |
20 March
8:30 | Clinical session Lung cancer and mesothelioma I |
|
|
10:30 | Coffee break |
11:00 | Clinical session Lung cancer and mesothelioma II |
|
|
12:00 | Tumour board Lung cancer |
13:00 | Lunch |
14:30 | Case presentations by participants |
16:00 | Sponsored lecture Angiogenesis and anti-angiogenesis in ovarian cancer (SPCC lecture by Amgen) |
16:30 | Coffee break |
17:00 | Learning assessment test |
18:00 | Sponsored lecture European consensus paper on GIST management (SPCC lecture by Novartis) |
18:30 | Sponsored lecture Considerations on maintenance treatment |
19:30 | Dinner |
21 March
8:30 | Spotlight session 7 Rare Cancers P. Casali, IT |
9:30 | JOINT medics and nursing session I |
|
|
10:30 | Coffee break |
11:00 | JOINT medics and nursing session II |
| |
12:00 | Close |